Q67H (p.Gln67His) variant of CALR (Calreticulin)

Q67H (p.Gln67His) in CALR (Calreticulin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.39 / 1. The record also includes population frequency data and structural context.

Q67H (p.Gln67His) variant details